Publication | Closed Access
A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B
93
Citations
37
References
2010
Year
Treatment with peginterferon alpha-2a resulted in a limited sustained response rate in HBeAg-negative chronic hepatitis B patients. Addition of ribavirin did not improve response to therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1